2023 Partnering Organizations
Founded in 2002, ACRO represents the world’s leading clinical research and technology organizations, which provide specialized services that are integral to the development of
drugs, biologics and medical devices. ACRO and its members advocate on a global basis for safe, ethical, high-quality medical research so patients can benefit from the development of new treatments and therapies.
For more information visit: https://www.acrohealth.org/
CISCRP offers a portfolio of services to support patient engagement, clinical research education, and clinical trial participation for study volunteers, clinical research stakeholders,
and sponsor organizations. As an independent, neutral, nonprofit organization dedicated to patient outreach and education, CISCRP is uniquely positioned to assist with a variety of activities including developing plain language study specific
documents and clinical trial summaries, organizing and running patient & care partner advisory boards, conducting research to better understand public perceptions about research, and hosting community engagement events.
For more information, visit CISCRP or contact Joan Chambers at jchambers@ciscrp.org
ClinEco is a web-based platform and community that connects all the stakeholders of decentralized, hybrid and conventional clinical trials. The ClinEco platform and B2B marketplace enables accelerated identification of high-value providers and partners. Uncover innovative and emerging companies to expand your clinical trial capabilities.
We are onboarding leaders in clinical research to:
Explore the Ecosystem. Engage Partners. Exchange Capabilities.
Join the B2B community today at clineco.io or email sramirez@clineco.io to schedule an onboarding session.
Cure SMA leads the way to a world without spinal muscular atrophy (SMA), the number one genetic cause of death for infants. We fund and direct comprehensive research that drives breakthroughs
in treatment and care, and we provide individuals with SMA and their families the support they need for today.
Alyssa Zavislak
Senior Development Manager
630-885-8473
alyssa.zavislak@curesma.org
DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality
resources on a tech timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Join us to advance the ethical,
effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives.
The Decentralized Trials & Research Alliance enables collaboration of stakeholders to accelerate the adoption of patient-focused, decentralized clinical trials and research within life
sciences and healthcare through education and research. Our vision is to make research participation accessible to everyone, enabled by the consistent, widespread adoption of appropriate decentralized research methods.
For more information, contact the DTRA Secretariat at secretariat@dtra.org.
The MedSurplus Alliance’s (MSA) Kits4Life Initiative is an award-winning program developed by the clinical research community to help close the healthcare gap worldwide. Lab kits, equipment,
and supplies donated via Kits4Life reach recipient aid organizations through MSA accredited Medical Surplus Recovery Organizations (MSROs), which ensure the supplies are used for health care, diagnostic labs, medical training programs,
and animal shelters in low resource settings. Kits4Life members include Bayer, Eli Lilly, Labcorp Drug Development, Janssen, Roche, Sanofi US, Sanofi Espoir Foundation, and the Society for Clinical Research Sites. Since 2020, over 184
clinical research sites in 30 U.S. states have participated.
If your organization wants more information on Kits4Life membership, please contact:
Josh Kravitz
The Task Force for Global Health
jkravitz-consultant@taskforce.org
The MedSurplus Alliance, a program of the Task Force for Global Health, engages and inspires cross-sector medical donation stakeholders to develop standards-based donation programs
and practices that advance quality donations and protect the environment. Through its code of conduct, accreditation program, and operational expertise, the Medsurplus Alliance improves medical donation quality while encouraging stakeholder-led
donation initiatives that expand healthcare delivery in low-resource settings.
If your organization wants to learn more about standards-based donations, please contact:
Lori Warrens
MedSuplus Alliance
lori.warrens@medsurplusalliance.org
The Leukemia and Lymphoma Society® (LLS) is global leader in the fight against cancer. We are the largest nonprofit dedicated to creating a world without blood cancers.
Since 1949, we’ve invested nearly $1.5 billion In groundbreaking research, pioneering many of today’s most innovative approaches. In addition to funding lifesaving blood cancer research around the world, LLS provides free information
and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Learn more. To find out more about our free services and how we can help you and your patients, contact an Information Specialist at 1 800 955-4572.
The Society for Clinical Research Sites (SCRS) was founded in response to the growing need for a global organization advocating for the needs of clinical research sites globally. SCRS is an influential
voice for sites and an active partner in industry-wide initiatives and dialogues with a focus on unifying the voice of the global clinical research site community for site sustainability. Representing more than 9,500 research sites in 47 countries,
SCRS provides sites with a community dedicated to advocacy, education, mentorship and connectivity. Learn more at myscrs.org
TransCelerate BioPharma is a collaborative consortium of the global R&D community who offers publicly available operational solutions that help unify knowledge to accelerate
how research becomes life-saving healthcare. Our innovations make the treatments of the future happen faster. TransCelerate aims to break down barriers and foster true collaboration among the global scientific community, the labs and clinical
trials sites where they conduct groundbreaking discoveries, and the health authorities that verify these breakthroughs.
For more information, contact Leigh Anne Minnier at leighanne.minnier@transceleratebiopharmainc.com.